Literature DB >> 11734619

Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations.

G Lee1, S Dallas, M Hong, R Bendayan.   

Abstract

Drug transport in the central nervous system is highly regulated not only by the blood-brain and the blood-cerebrospinal fluid barriers but also in brain parenchyma. The novel localization of drug transporters in brain parenchyma cells, such as microglia and astrocytes, suggest a reconsideration of the present conceptualization of brain barriers as it relates to drug transport. That is, the cellular membranes of parenchyma cells act as a second "barrier" to drug permeability and express transporters whose properties appear similar to those localized at the conventional brain barriers. This review will focus on the molecular characteristics, localization, and substrate specificities of several classes of well known membrane drug transporters (i.e., the organic cation, organic anion, nucleoside, P-glycoprotein, and multidrug resistance proteins) in the brain. Comparisons to similar transporters localized within the peripheral system and clinical implications of the functional expression of specific drug transport families will be discussed when appropriate. Nutrient and neurotransmitter transporters, whose characteristics have been reviewed extensively elsewhere, will not be considered in this review.

Mesh:

Substances:

Year:  2001        PMID: 11734619

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  76 in total

Review 1.  Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders.

Authors:  Gloria Lee; Reina Bendayan
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

Review 2.  A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury.

Authors:  Kevin W McConeghy; Jimmi Hatton; Lindsey Hughes; Aaron M Cook
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

3.  In vitro and in vivo investigation of dexibuprofen derivatives for CNS delivery.

Authors:  Xuan Zhang; Xing Liu; Tao Gong; Xun Sun; Zhi-rong Zhang
Journal:  Acta Pharmacol Sin       Date:  2012-02       Impact factor: 6.150

4.  Efficiency of Penetration of Dopamine and Serotonin Peptide Derivatives through the Artificial Membranes.

Authors:  V P Shevchenko; L A Andreeva; I Yu Nagaev; K V Shevchenko; N F Myasoedov
Journal:  Dokl Biochem Biophys       Date:  2019-11-25       Impact factor: 0.788

5.  Potential gamma-hydroxybutyric acid (GHB) drug interactions through blood-brain barrier transport inhibition: a pharmacokinetic simulation-based evaluation.

Authors:  Indranil Bhattacharya; Kathleen M K Boje
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-08-29       Impact factor: 2.745

6.  Microarray analysis of newly synthesized RNA in cells and animals.

Authors:  M Kenzelmann; S Maertens; M Hergenhahn; S Kueffer; A Hotz-Wagenblatt; L Li; S Wang; C Ittrich; T Lemberger; R Arribas; S Jonnakuty; M C Hollstein; W Schmid; N Gretz; H J Gröne; G Schütz
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-03       Impact factor: 11.205

7.  1α,25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells.

Authors:  Matthew R Durk; Gary N Y Chan; Christopher R Campos; John C Peart; Edwin C Y Chow; Eason Lee; Ronald E Cannon; Reina Bendayan; David S Miller; K Sandy Pang
Journal:  J Neurochem       Date:  2012-11-01       Impact factor: 5.372

8.  Expression profiling of the solute carrier gene family in the mouse brain.

Authors:  Amber Dahlin; Josh Royall; John G Hohmann; Joanne Wang
Journal:  J Pharmacol Exp Ther       Date:  2009-01-29       Impact factor: 4.030

9.  Blood-spinal cord barrier after spinal cord injury: relation to revascularization and wound healing.

Authors:  William D Whetstone; Jung-Yu C Hsu; Manuel Eisenberg; Zena Werb; Linda J Noble-Haeusslein
Journal:  J Neurosci Res       Date:  2003-10-15       Impact factor: 4.164

10.  The effect of quinidine, used as a probe for the involvement of P-glycoprotein, on the intestinal absorption and pharmacodynamics of methadone.

Authors:  Evan D Kharasch; Christine Hoffer; Dale Whittington
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.